Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ADAC Laboratories

This article was originally published in The Gray Sheet

Executive Summary

Enters agreement with Community Health Computing Corp., a Houston, Texas-based information systems firm, under which ADAC will loan CHCC up to $3.5 mil. The loan must be repaid by Dec. 31, and will allow CHCC to "meet certain short-term obligations while ADAC and CHCC pursue the possibility of additional relationships," ADAC says. In addition, ADAC reports that it has obtained a three year option to acquire about 4.8 mil. shares in CHCC for 30 cents per share. Recently, CHCC has been trading on NASDAQ for around $1 per share. ADAC is working to expand its health care information business, which is currently focused on the radiology area, and says that "any future relationship with CHCC would be consistent with that plan." The company notes that CHCC has a "large installed base" of systems, particularly in the laboratory information systems field. In addition, CHCC is developing the LabStat open architecture laboratory information system

Latest Headlines
See All
UsernamePublicRestriction

Register

MT003135

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel